The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians

Clinical Endocrinology

Volumn 74, Issue 6, 2011, Pages 783-790

  Vaidya, Anand ^a,e   Sun, Bei ^a   Forman, John P ^b   Hopkins, Paul N ^b   Brown, Nancy J ^c   Kolatkar, Nikheel S ^d   Williams, Gordon H ^a   Williams, Jonathan S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d GENENTECH INC   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; PROTEIN FOK1; RENIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM INTAKE; SODIUM RESTRICTION; VITAMIN BLOOD LEVEL;

ADULT; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RENIN; SODIUM CHLORIDE, DIETARY; VITAMIN D;

EID: 79955830919     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.03991.x     Document Type: Article

References (37)

1. Forman, J.P., Giovannucci, E., Holmes, M.D., et al. (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension, 49, 1063-1069. (Pubitemid 351664326)
2. Vaidya, A., &, Forman, J.P., (2010) Vitamin D and hypertension: current evidence and future directions. Hypertension, 56, 774-779.
3. Mazzolai, L., Nussberger, J., Aubert, J.F., et al. (1998) Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension, 31, 1324-1330. (Pubitemid 28248835)
4. Dluhy, R.G., &, Williams, G.H., (2004) Aldosterone-villain or bystander? New England Journal of Medicine, 351, 8-10.
5. Li, Y.C., Kong, J., Wei, M., et al. (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Journal of Clinical Investigation, 110, 229-238. (Pubitemid 34787360)
6. Bouillon, R., Carmeliet, G., Verlinden, L., et al. (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrine Reviews, 29, 726-776.
7. Zhou, C., Lu, F., Cao, K., et al. (2008) Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney International, 74, 170-179. (Pubitemid 351915078)
8. Kong, J., Qiao, G., Zhang, Z., et al. (2008) Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium. Kidney International, 74, 1577-1581.
9. Yuan, W., Pan, W., Kong, J., et al. (2007) 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. Journal of chemical Biology, 282, 29821-29830. (Pubitemid 350035242)
10. Resnick, L.M., Muller, F.B., &, Laragh, J.H., (1986) Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Annals of Internal Medicine, 105, 649-654. (Pubitemid 17176965)
11. Resnick, L.M., Nicholson, J.P., &, Laragh, J.H., (1986) Calcium metabolism in essential hypertension: relationship to altered renin system activity. Federation Proceedings, 45, 2739-2745. (Pubitemid 17187443)
12. Tomaschitz, A., Pilz, S., Ritz, E., et al. (2010) Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Clinica Chimica Acta, 411, 1354-1360.
13. Vaidya, A., Forman, J.P., &, Williams, J.S., (2011) 25-hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians. Journal of the Renin-Angiotensin-Aldosterone System (in press).
14. Forman, J.P., Williams, J.S., &, Fisher, N.D., (2010) Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension, 55, 1283-1288.
15. Vaidya, A., Forman, J.P., Williams, J.S., (2010) Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension. The Journal of Human Hypertension, epub ahead of print.
16. Uitterlinden, A.G., Fang, Y., Van Meurs, J.B., et al. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene, 338, 143-156. (Pubitemid 39094759)
17. McGrath, J.J., Saha, S., Burne, T.H., et al. (2010) A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. Journal of Steroid Biochemistry and Molecular Biology, 121, 471-477.
18. Randerson-Moor, J.A., Taylor, J.C., Elliott, F., et al. (2009) Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. European Journal of Cancer, 45, 3271-3281.
19. Kostner, K., Denzer, N., Muller, C.S., et al. (2009) The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Research, 29, 3511-3536.
20. Abrams, S.A., Griffin, I.J., Hawthorne, K.M., et al. (2005) Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. Journal of Bone and Mineral Research, 20, 945-953. (Pubitemid 40712818)
21. Ames, S.K., Ellis, K.J., Gunn, S.K., et al. (1999) Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. Journal of Bone and Mineral Research, 14, 740-746. (Pubitemid 29210600)
22. Chatzipapas, C., Boikos, S., Drosos, G.I., et al. (2009) Polymorphisms of the vitamin D receptor gene and stress fractures. Hormone and Metabolic Research, 41, 635-640.
23. McClung, J.P., &, Karl, J.P., (2010) Vitamin D and stress fracture: the contribution of vitamin D receptor gene polymorphisms. Nutrition Reviews, 68, 365-369.
24. Zmuda, J.M., Cauley, J.A., &, Ferrell, R.E., (2000) Molecular epidemiology of vitamin D receptor gene variants. Epidemiologic Reviews, 22, 203-217. (Pubitemid 32116092)
25. Price, D.A., Fisher, N.D., Lansang, M.C., et al. (2002) Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin with salt. Hypertension, 40, 186-189. (Pubitemid 34840096)
26. Hopkins, P.N., Hunt, S.C., Jeunemaitre, X., et al. (2002) Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension. Circulation, 105, 1921-1927. (Pubitemid 34437619)
27. Chamarthi, B., Williams, J.S., &, Williams, G.H., (2010) A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II. Journal of Hypertension, 28, 1020-1026.
28. Holick, M.F., (2007) Vitamin D deficiency. New England Journal of Medicine, 357, 266-281.
29. Arabi, A., El Rassi, R., &, El-Hajj Fuleihan, G., (2010) Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nature Reviews. Endocrinology., 6, 550-561.
30. Arai, H., Miyamoto, K., Taketani, Y., et al. (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. Journal of Bone and Mineral Research, 12, 915-921. (Pubitemid 27225001)
31. Jurutka, P.W., Remus, L.S., Whitfield, G.K., et al. (2000) The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Molecular Endocrinology, 14, 401-420. (Pubitemid 32260532)
32. Colin, E.M., Weel, A.E., Uitterlinden, A.G., et al. (2000) Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clinical Endocrinology (Oxford), 52, 211-216. (Pubitemid 30108268)
33. Gross, C., Krishnan, A.V., Malloy, P.J., et al. (1998) The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. Journal of Bone and Mineral Research, 13, 1691-1699. (Pubitemid 28491998)
34. Grant, F.D., Mandel, S.J., Brown, E.M., et al. (1992) Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. Journal of Clinical Endocrinology and Metabolism, 75, 988-992.
35. Tomaschitz, A., &, Pilz, S., (2010) Aldosterone to renin ratio-a reliable screening tool for primary aldosteronism? Hormone and Metabolic Research, 42, 382-391.
36. de Zeeuw, D., Agarwal, R., Amdahl, M., et al. (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet, 376, 1543-1551.
37. Tripathi, G., Sharma, R., Sharma, R.K., et al. (2010) Vitamin D receptor genetic variants among patients with end-stage renal disease. Renal Failure, 32, 969-977.